Optimal control of the chemotherapy of HIV

DOI10.1007/s002850050076zbMath0876.92016OpenAlexW2033593383WikidataQ52258657 ScholiaQ52258657MaRDI QIDQ1365081

Denise E. Kirschner, Suzanne M. Lenhart, Steven M. Serbin

Publication date: 25 November 1997

Published in: Journal of Mathematical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/s002850050076

zbMATH Keywords

HIVchemotherapyoptimal chemotherapy strategy

Mathematics Subject Classification ID

Application models in control theory (93C95) Medical applications (general) (92C50) Control/observation systems governed by ordinary differential equations (93C15)

Related Items

FEEDBACK CONTROL OF THE CHEMOTHERAPY OF HIV, Short and long period optimization of drug doses in the treatment of AIDS, Sparse Optimal Control of Pattern Formations for an SIR Reaction-Diffusion Epidemic Model, Costs versus benefits: best possible and best practical treatment regimens for HIV, The cost-effectiveness analysis and optimal strategy of the tobacco control, Optimal control of combined antiretroviral therapies in an HIV infection model with cure rate and fusion effect, Stabilization of HIV/AIDS model by receding horizon control, SATURATION EFFECTS FOR CTL MEDIATED CONTROL OF HIV-1 INFECTION: A MATHEMATICAL STUDY, Dynamics of a stochastic SICA epidemic model for HIV transmission with higher-order perturbation, OPTIMAL CONTROL ON RELIABILITY PROBLEMS, Robust H∞ observer-based tracking control of stochastic immune systems under environmental disturbances and measurement noises, Immune therapeutic strategies using optimal controls with \(L^{1}\) and \(L^{2}\) type objectives, Mathematical analysis of the role of HIV/HBV latency in hepatocytes, Modeling transmission dynamics of Ebola virus disease, Mathematical modelling of HIV-1 transcription inhibition: a comparative study between optimal control and impulsive approach, Optimal control strategies for an age‐structured SEIR epidemic model, A stochastic HIV/HTLV-I co-infection model incorporating the AIDS-related cancer cells, Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting, Behavior of trajectories of a four-dimensional model of HIV infection, Optimal and sub-optimal quarantine and isolation control in SARS epidemics, Role of optimal screening and treatment on infectious diseases dynamics in presence of self-protection of susceptible, Optimal Control Analysis of Fascioliasis Disease Transmission Dynamics, Optimal Control for a SIR Epidemic Model with Nonlinear Incidence Rate, An age-structured model with immune response of HIV infection: modeling and optimal control approach, Stability of a delayed SARS-CoV-2 reactivation model with logistic growth and adaptive immune response, Unnamed Item, Unnamed Item, MODELING ZIKA TRANSMISSION DYNAMICS: PREVENTION AND CONTROL, Optimal control of chemotherapy of HIV model using the coupled Adomian/Alienor methods, OPTIMAL DOSING STRATEGIES AGAINST SUSCEPTIBLE AND RESISTANT BACTERIA, Optimal control of innate immune response, AVIAN INFLUENZA OPTIMAL SEASONAL VACCINATION STRATEGY, Control of the medical treatment of AIDS, REVIEW OF HIV MODELS: THE ROLE OF THE NATURAL IMMUNE RESPONSE AND IMPLICATIONS FOR TREATMENT, Optimal control of a delayed smoking model with immigration, TRANSMISSION DYNAMICS AND OPTIMAL CONTROL OF AN INFLUENZA MODEL WITH QUARANTINE AND TREATMENT, The role of asymptomatic class, quarantine and isolation in the transmission of COVID-19, Optimal strategy for controlling the spread of HIV/AIDS disease: a case study of South Africa, Optimal trajectories for angular systems on the projective line, Treatment Monitoring of HIV‐Infected Patients based on Mechanistic Models, Optimal control of treatment in a mathematical model of chronic myelogenous leukemia, Nonautonomous Dynamical Systems in the Life Sciences, Comparison of optimal controls for a model in cancer chemotherapy withL₁- andL₂-type objectives, Genetic Instability in Cancer: An Optimal Control Problem, A parameter sensitivity methodology in the context of HIV delay equation models, Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection, Optimal control and infectiology: Application to an HIV/AIDS model, Optimal control strategy of HIV-1 epidemic model for recombinant virus, Mathematical analysis of an influenza epidemic model, formulation of different controlling strategies using optimal control and estimation of basic reproduction number, Optimal control for a tuberculosis model with undetected cases in Cameroon, Optimal Control Measures for Tuberculosis in a Population Affected with Insurgency, ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY, THE IMPACT OF THE CD8+ CELL NON-CYTOTOXIC ANTIVIRAL RESPONSE (CNAR) AND CYTOTOXIC T LYMPHOCYTE (CTL) ACTIVITY IN A CELL-TO-CELL SPREAD MODEL FOR HIV-1 WITH A TIME DELAY, Unnamed Item, HIV dynamics: Modeling, data analysis, and optimal treatment protocols, Receding Horizon Control of HIV, OPTIMAL CONTROL ANALYSIS OF A HUMAN–BOVINE SCHISTOSOMIASIS MODEL, DYNAMICS OF AN INFECTIOUS DISEASE IN THE PRESENCE OF SATURATED MEDICAL TREATMENT OF HOLLING TYPE III AND SELF-PROTECTION, Periodically varying antiviral therapies: conditions for global stability of the virus free state, Unnamed Item, Optimal control in a multi-pathways HIV-1 infection model: a comparison between mono-drug and multi-drug therapies, Free terminal time optimal control problem of an HIV model based on a conjugate gradient method, Incorporation of variability into the modeling of viral delays in HIV infection dynamics, Malaria and COVID-19 co-dynamics: a mathematical model and optimal control, Chaotic dynamics of a fractional order HIV-1 model involving AIDS-related cancer cells, Robust set-point regulation for ecological models with multiple management goals, Mathematical modeling and numerical simulation of HIV infection model, Optimal control strategy for prevention of avian influenza pandemic, Stochastic optimal therapy for enhanced immune response, Optimal treatment strategies derived from a HIV model with drug-resistant mutants, Optimal control of zika virus infection by vector elimination, vector-to-human and human-to-human contact reduction, Transmission dynamics and optimal control of measles epidemics, Optimal control of infectious disease: information-induced vaccination and limited treatment, A computational study of HSV-2 with poor treatment adherence, Within-host virus models with periodic antiviral therapy, Models of disease vector control: when can aggressive initial intervention lower long-term cost?, Can the viral reservoir of latently infected \(CD4^{+}\) T cells be eradicated with antiretroviral HIV drugs?, Optimal control of Aedes aegypti mosquitoes by the sterile insect technique and insecticide, Global stability analysis and control of leptospirosis, Toward a model-free feedback control synthesis for treating acute inflammation, Dynamics of a stochastic cell-to-cell HIV-1 model with distributed delay, Threshold dynamics and optimal control of an age-structured giving up smoking model, Viable control of an epidemiological model, Dynamical analysis of chemotherapy models with time-dependent infusion, Mathematical model and intervention strategies for mitigating tuberculosis in the Philippines, Optimal control analysis of malaria-schistosomiasis co-infection dynamics, A general framework for multi-compartmental analysis of drug chemotherapy dynamics in human immunodeficiency virus type-1 infected individuals, Optimal control for HIV treatment, Optimal control in HIV chemotherapy with termination viral load and latent reservoir, Optimal control strategies for a new ecosystem governed by reaction-diffusion equations, Optimal control of a delayed HIV infection model with immune response using an efficient numerical method, Modeling and control for HIV/AIDS transmission in China based on data from 2004 to 2016, A fractional calculus model for HIV dynamics: real data, parameter estimation and computational strategies, Dynamical behaviour of HIV infection with the influence of variable source term through Galerkin method, Pulse HIV vaccination: feasibility for virus eradication and optimal vaccination schedule, Comparison of three kinetic models of HIV-1 infection: implications for optimization of treatment, Optimal control of a delayed HIV model, Optimal control of the transmission dynamics of tuberculosis, Short-term antiretroviral treatment recommendations based on sensitivity analysis of a mathematical model for HIV infection of CD4\(^+\)T cells, Optimal campaign in the smoking dynamics, Short- and long-term optimal control of a mathematical model for HIV infection of \(CD4^{+}T\) cells, Numerical methods of optimal control of the HIV-infection dynamics, Global properties of a delayed HIV infection model with CTL immune response, A controlled treatment strategy applied to HIV immunology model, Estimation of HIV/AIDS parameters., Mathematical insights on psoriasis regulation: role of \(\mathrm{Th}_{1}\) and \(\mathrm{Th}_{2}\) cells, A model of optimal dosing of antibiotic treatment in biofilm, An efficient therapy strategy under a novel HIV model, Optimal control of a delayed HIV infection model via Fourier series, Optimal control strategies for a reaction-diffusion epidemic system, Mutation and control of the human immunodeficiency virus, Controlling the number of HIV infectives in a mobile population, Switching neuronal state: optimal stimuli revealed using a stochastically-seeded gradient algorithm, Optimal strategy of vaccination \& treatment in an \textit{SIR} epidemic model, Fastest time to cancer by loss of tumor suppressor genes, Conflict and accord of optimal treatment strategies for HIV infection within and between hosts, Optimal control of acute myeloid leukaemia, The complex dynamics of hepatitis B infected individuals with optimal control, Optimal control for disease vector management in SIT models: an integrodifference equation approach, Cost-effectiveness analysis of optimal strategy for tumor treatment, Optimal homotopy analysis of a chaotic HIV-1 model incorporating AIDS-related cancer cells, Optimal control techniques on a mathematical model for the dynamics of Tungiasis in a community, Investigation of nonlinear epidemiological models for analyzing and controlling the MERS outbreak in Korea, Optimal control and cost-effectiveness analysis of a three age-structured transmission dynamics of Chikungunya virus, Optimal control of a multi-level dynamic model for biofuel production, An optimal strategy for HIV multitherapy, Dynamic programming approach to the numerical solution of optimal control with paradigm by a mathematical model for drug therapies of HIV/AIDS, Optimal control of HIV dynamic using embedding method, Using artificial intelligence and computer technologies for developing treatment programs for complex immune diseases, Backward bifurcation and optimal control in transmission dynamics of West Nile virus, Optimal control of an age-structured model of HIV infection, HIV dynamics: analysis and robust multirate MPC-based treatment schedules, Stability and feedback stabilization of HIV infection model with two classes of target cells, Global properties of a class of HIV models, A dynamic model for tuberculosis transmission and optimal treatment strategies in South Korea, Optimal control of differential infectivity models, Multiobjective optimization to a TB-HIV/AIDS coinfection optimal control problem, Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis, Optimal control strategies for a two-group epidemic model with vaccination-resource constraints, Robust model matching control of immune systems under environmental disturbances: dynamic game approach, Optimal control of an SIR epidemic through finite-time non-pharmaceutical intervention, Optimal control of methicillin-resistant \textit{Staphylococcus aureus} transmission in hospital settings, Mathematical analysis of HIV/AIDS stochastic dynamic models, Evolutionary game based control for biological systems with applications in drug delivery, Optimal controls of the highly active antiretroviral therapy, Stationary distribution and extinction of a stochastic HIV-1 infection model with distributed delay and logistic growth, Optimal control strategy for an age-structured SIR endemic model, Analysis of tuberculosis model with saturated incidence rate and optimal control, Geometric approach to Pontryagin's maximum principle, Optimal treatment in a multi-strain within-host model of HIV with age structure, On optimal delivery of combination therapy for tumors, A delay-differential equation model of HIV infection of \(\text{CD}4^+\) T-cells, A co-infection model of malaria and cholera diseases with optimal control, Combating COVID-19 crisis and predicting the second wave in Europe: an age-structured modeling, Optimal bang-bang controls for a two-compartment model in cancer chemotherapy, Sufficient conditions for relative minima of broken extremals in optimal control theory, Dynamical analysis and control strategies in modelling Ebola virus disease, Dynamics of HIV infection on 2D cellular automata, A TB-HIV/AIDS coinfection model and optimal control treatment, Optimal control of pattern formations for an SIR reaction-diffusion epidemic model, Mathematical analysis of swine influenza epidemic model with optimal control